Astrazeneca is subject of EU antitrust probe

被引：0

作者：

Van Arnum, Patricia

机构：

来源：

Chemical Market Reporter | 2003年 / 264卷 / 04期

关键词：

Competition - Drug products plants - Laws and legislation - Marketing - Patents and inventions;

D O I：

暂无

中图分类号：

学科分类号：

摘要：

The antitrust investigations on AstraZeneca, by the European Union (EU) are discussed. The EU has alleged that the drug giant was engaged in practices to block or delay generic entrants of its top-selling drug. The allegations also involve misrepresentations before the national patent offices for obtaining supplementary protection certificates.

引用